题名

Recent Scientific Studies of a Traditional Chinese Medicine, Tea, on Prevention of Chronic Diseases

DOI

10.4103/2225-4110.124326

作者

Chung S. Yang；Gang Chen；Qing Wu

关键词

Cancer ； Cardiovascular diseases ； Diabetes ； Green tea ； Metabolic syndrome ； Obesity

期刊名称

Journal of Traditional and Complementary Medicine

卷期/出版年月

4卷1期（2014 / 01 / 01）

页次

17 - 23

内容语文

英文
中文摘要

Green tea (綠茶 Lǜ Chá), made from the leaves of the plant Camellia sinensis, has traditionally been used as a medicine in China for thousands of years. According to the classical work of Li Shizhen (李時珍 Lǐ Shí Zhēn) of the Ming Dynasty, ＂tea is cold and lowers the fire.＂ Since fire (inflammation) causes many diseases, could tea be effective in the prevention of many diseases? The possible prevention of chronic diseases such as cancer, metabolic syndrome, obesity, diabetes, and cardiovascular diseases has been studied with contemporary scientific methods, and the results are promising. The molecular mechanisms underlining these observations will be discussed in this presentation. One of the reasons for the failure to demonstrate a disease-preventive effect of tea in some epidemiological studies is the lower quantities of tea consumption in humans. Can we increase the quantity of tea consumption to harness its health benefits without causing gastrointestinal irritation? This is a topic for further research.
主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. Axling, U,Olsson, C,Xu, J,Fernandez, C,Larsson, S,Strom, K(2012).Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high‑fat fed C57BL/6J mice.Nutr Metab,9,105.
  2. Balentine, DA,Wiseman, SA,Bouwens, LC(1997).The chemistry of tea flavonoids.Criti Rev Food Sci Nutr,37,693-704.
  3. Basu, A,Sanchez, K,Leyva, MJ,Wu, M,Betts, NM,Aston, CE(2010).Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome.J Am Coll Nutr,29,31-40.
  4. Bettuzzi, S,Brausi, M,Rizzi, F,Castagnetti, G,Peracchia, G,Corti, A(2006).Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high‑grade prostate intraepithelial neoplasia: Apreliminary report from a one‑year proof‑of‑principle study.Cancer Res,66,1234-1240.
  5. Bose, M,Lambert, JD,Ju, J,Reuhl, KR,Shapses, SA,Yang, CS(2008).The major green tea polyphenol, (‑)‑epigallocatechin‑3‑gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high‑fat‑fed mice.J Nutr,138,1677-1683.
  6. Chang, CS,Chang, YF,Liu, PY,Chen, CY,Tsai, YS,Wu, CH(2012).Smoking, habitual tea drinking and metabolic syndrome in elderly men living in rural community: The Tianliao old people (TOP) study 02.PloS One,7,e38874.
  7. Chen, H,Hayek, S,Rivera Guzman, J,Gillitt, ND,Ibrahim, SA,Jobin, C(2012).The microbiota is essential for the generation of black tea theaflavins‑derived metabolites.PLoS One,7,e51001.
  8. Chen, YK,Cheung, C,Reuhl, KR,Liu, AB,Lee, MJ,Lu, YP(2011).Effects of green tea polyphenol (‑)‑epigallocatechin‑3‑gallate on newly developed high‑fat/Western‑style diet‑induced obesity and metabolic syndrome in mice.J Agric Food Chem,59,11862-11871.
  9. Chow, HH,Hakim, IA(2011).Pharmacokinetic and chemoprevention studies on tea in humans.Pharmacol Res,64,105-112.
  10. Deka, A,Vita, JA(2011).Tea and cardiovascular disease.Pharmacol Res,64,136-145.
  11. Di Castelnuovo, A,di Giuseppe, R,Iacoviello, L,de Gaetano, G.(2012).Consumption of cocoa, tea and coffee and risk of cardiovascular disease.Eur J Intern Med,23,15-25.
  12. Feng, L,Gwee, X,Kua, EH,Ng, TP(2010).Cognitive function and tea consumption in community dwelling older Chinese in Singapore.J Nutr Health Aging,14,433-438.
  13. Ford, ES(2005).Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S..Diabetes Care,28,2745-2749.
  14. Friedrich, M,Petzke, KJ,Raederstorff, D,Wolfram, S,Klaus, S(2012).Acute effects of epigallocatechin gallate from green tea on oxidation and tissue incorporation of dietary lipids in mice fed a high‑fat diet.Int J Obes,36,735-743.
  15. Gao, YT,McLaughlin, JK,Blot, WJ,Ji, BT,Dai, Q,Fraumeni, JF, Jr(1994).Reduced risk of esophageal cancer associated with green tea consumption.J Natl Cancer Inst,86,855-858.
  16. Goldbohm, RA,Hertog, MG,Brants, HA,van Poppel, G,van den Brandt, PA(1996).Consumption of black tea and cancer risk: A prospective cohort study.Natl Cancer Inst,88,93-100.
  17. Hara, Y(2011).Tea catechins and their applications as supplements and pharmaceutics.Pharmacol Res,64,100-104.
  18. Hodgson, JM,Puddey, IB,Mori, TA,Burke, V,Baker, RI,Beilin, LJ(2001).Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans.Eur J Clin Nutr,55,881-886.
  19. Hursel, R,Viechtbauer, W,Dulloo, AG,Tremblay, A,Tappy, L,Rumpler, W(2011).The effects of catechin rich teas and caffeine on energy expenditure and fat oxidation: A meta‑analysis.Obesity Rev,12,e573-e581.
  20. Hursel, R,Viechtbauer, W,Westerterp‑Plantenga, MS(2009).The effects of green tea on weight loss and weight maintenance: A meta‑analysis.Int J Obes,33,956-961.
  21. Iso, H,Date, C,Wakai, K,Fukui, M,Tamakoshi, A(2006).The relationship between green tea and total caffeine intake and risk for self‑reported type 2 diabetes among Japanese adults.Ann Intern Med,144,554-562.
  22. Jemnitz, K,Heredi‑Szabo, K,Janossy, J,Ioja, E,Vereczkey, L,Krajcsi, P(2010).ABCC2/Abcc2: A multispecific transporter with dominant excretory functions.Drug Metab Rev,42,402-436.
  23. Jin, JS,Touyama, M,Hisada, T,Benno, Y(2012).Effects of green tea consumption on human fecal microbiota with special reference to Bifidobacterium species.Microbiol Immunol,56,729-739.
  24. Kuriyama, S,Shimazu, T,Ohmori, K,Kikuchi, N,Nakaya, N,Nishino, Y(2006).Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The Ohsaki study.JAMA,296,1255-1265.
  25. Kushiyama, M,Shimazaki, Y,Murakami, M,Yamashita, Y(2009).Relationship between intake of green tea and periodontal disease.J Periodontol,80,372-377.
  26. Li, C,Lee, MJ,Sheng, S,Meng, X,Prabhu, S,Winnik, B(2000).Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion.Chem Res Toxicol,13,177-184.
  27. Li, Y,Zhao, S,Zhang, W,Zhao, P,He, B,Wu, N(2011).Epigallocatechin‑3‑O‑gallate (EGCG) attenuates FFAs‑induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo.Diabetes Res Clin Pract,93,205-214.
  28. Liang, W,Lee, AH,Binns, CW,Huang, R,Hu, D,Zhou,Q(2009).Tea consumption and ischemic stroke risk: A case‑control study in southern China.Stroke,40,2480-2485.
  29. Lipinski, CA,Lombardo, F,Dominy, BW,Feeney, PJ(2001).Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.Adv Drug Deliv Rev,46,3-26.
  30. Mineharu, Y,Koizumi, A,Wada, Y,Iso, H,Watanabe, Y,Date, C(2011).Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women.J Epidemiol Community Health,65,230-240.
  31. Murase, T,Misawa, K,Haramizu, S,Hase, T(2009).Catechin‑induced activation of the LKB1/AMP‑activated protein kinase pathway.Biochem Pharmacol,78,78-84.
  32. Phung, OJ,Baker, WL,Matthews, LJ,Lanosa, M,Thorne, A,Coleman, CI(2010).Effect of green tea catechins with or without caffeine on anthropometric measures: A systematic review and meta‑analysis.Am J Clin Nutr,91,73-81.
  33. Qin, B,Polansky, MM,Harry, D,Anderson, RA(2010).Green tea polyphenols improve cardiac muscle mRNA and protein levels of signal pathways related to insulin and lipid metabolism and inflammation in insulin‑resistant rats.Mol Nutr Food Res,54(Suppl 1),S14-S23.
  34. Sae‑tan, S,Grove, KA,Lambert, JD(2011).Weight control and prevention of metabolic syndrome by green tea.Pharmacol Res,64,146-154.
  35. Sang, S,Lambert, JD,Ho, CT,Yang, CS(2011).The chemistry and biotransformation of tea constituents.Pharmacol Res,64,87-99.
  36. Sasazuki, S,Tamakoshi, A,Matsuo, K,Ito, H,Wakai, K,Nagata, C(2012).Green tea consumption and gastric cancer risk: An evaluation based on a systematic review of epidemiologic evidence among the Japanese population.Japan J Clin Pncol,42,335-346.
  37. Serisier, S,Leray, V,Poudroux, W,Magot, T,Ouguerram, K,Nguyen, P(2008).Effects of green tea on insulin sensitivity, lipid profile and expression of PPARalpha and PPARgamma and their target genes in obese dogs.Br J Nutr,99,1208-1216.
  38. Shimizu, M,Fukutomi, Y,Ninomiya, M,Nagura, K,Kato, T,Araki, H(2008).Green tea extracts for the prevention of metachronous colorectal adenomas: A pilot study.Cancer Epidemiol Biomarkers Prev,17,3020-3025.
  39. Song, Y,Manson, JE,Buring, JE,Sesso, HD,Liu, S(2005).Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: Aprospective study and cross‑sectional analysis.J Am Coll Nutr,24,376-384.
  40. Vernarelli, JA,Lambert, JD(2013).Tea consumption is inversely associated with weight status and other markers for metabolic syndrome in US adults.Eur J Nutr,52,1039-1048.
  41. Wang, H,Wen, Y,Du, Y,Yan, X,Guo, H,Rycroft, JA(2010).Effects of catechin enriched green tea on body composition.Obesity,18,773-779.
  42. Wang, J,Zhang, W,Sun, L,Yu, H,Ni, QX,Risch, HA(2012).Green tea drinking and risk of pancreatic cancer: A large‑scale, population‑based case‑control study in urban Shanghai.Cancer Epidemiol,36,e254-e258.
  43. Wang, ZM,Zhou, B,Wang, YS,Gong, QY,Wang, QM,Yan, JJ(2011).Black and green tea consumption and the risk of coronary artery disease: A meta‑analysis.Am J Clin Nutr,93,506-515.
  44. Yan, J,Zhao, Y,Suo, S,Liu, Y,Zhao, B(2012).Green tea catechins ameliorate adipose insulin resistance by improving oxidative stress.Free Radic Biol Med,52,1648-1657.
  45. Yang, CS,Hong, J(2013).Prevention of chronic diseases by tea: Possible mechanisms and human relevance.Annu Rev Nutr,33,161-181.
  46. Yang, CS,Sang, S,Lambert, JD,Lee, MJ(2008).Bioavailability issues in studying the health effects of plant polyphenolic compounds.Mol Nutr Food Res,52(Suppl 1),S139-S151.
  47. Yang, CS,Wang, H,Li, GX,Yang, Z,Guan, F,Jin, H(2011).Cancer prevention by tea: Evidence from laboratory studies.Pharmacol Res,64,113-122.
  48. Yang, CS,Wang, X,Lu, G,Picinich, SC(2009).Cancer prevention by tea: Animal studies, molecular mechanisms and human relevance.Nat Rev Cancer,9,429-439.
  49. Yang, G,Zheng, W,Xiang, YB,Gao, J,Li, HL,Zhang, X(2011).Green tea consumption and colorectal cancer risk: Areport from the Shanghai Men’s Health Study.Carcinogenesis,32,1684-1688.
  50. Yuan, JM,Sun, C,Butler, LM.(2011).Tea and cancer prevention: Epidemiological studies.Pharmacol Res,64,123-135.
print cancel